Author Archives: Patricia Silva PhD

#PHAware: Who Are Steve and Lucas Van Wormer?

Steve Van Wormer and Lucas Van Wormer are now among the most prominent faces in the fight against pulmonary hypertension (PH). But who are they? The story of this family is intrinsically marked by an unimaginable turn, the global movement #PHAware, and the chronic disease that is characterized by high…

Galectin-3 Inhibitors Show Positive Preclinical Results for PAH Vascular Remodeling

Galectin Therapeutics recently announced that GR-MD-02, its galectin-3 (gal-3) inhibitor in development-stage, has shown a positive effect on vascular remodeling in an animal model of pulmonary arterial hypertension (PAH). Galectin proteins are key mediators of biologic function. The announcement was made during a poster presentation of the company’s preclinical results at…

PH YouTube Star: The Story of Chloe Temtchine

Chloe Temtchine is a celebrity and singer like many others, but she is also a pulmonary hypertension (PH) patient who uses her talent to raise awareness for the disease. The breathing tubes that the singer needs to use while singing became her mark, while her music became an inspiration for patients…

PH: Focusing on Emotional Health and Optimizing Quality of Life

https://www.youtube.com/watch?v=5KX_0biPgmQ Pulmonary hypertension (PH) is a disease characterized by high blood pressure in the arteries of the lungs and right side of the heart. Patients often experience symptoms such as shortness of breath (dyspnea), fatigue, dizziness or fainting spells (syncope), chest pressure or pain, swelling (edema) in the ankles, legs and…

Reviva Presents Positive Results on RP5063 for Pulmonary Arterial Hypertension at ATS 2016

Reviva Pharmaceuticals, Inc. recently presented positive preclinical efficacy results for RP5063 in pulmonary arterial hypertension (PAH) at the American Thoracic Society (ATS) 2016 International Conference, held in San Francisco from May 13-18. RP5063 is a novel atypical antipsychotic drug with a relatively unique pharmacology and a novel target for treating PAH. Its…